Topal, A.; Başak, M. Evaluating the Role of HER2-Low Versus HER2-0 Status in Predicting Response to Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer. Eur Res J 2025, 11 (5), 858-867. https://doi.org/10.18621/eurj.1704067.